Evan Seigerman
Stock Analyst at BMO Capital
(4.50)
# 1,070
Out of 4,581 analysts
1024
Total ratings
55.3%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterated: Hold | $196 → $208 | $206.68 | +0.64% | 63 | Jul 30, 2026 | |
| INCY Incyte | Maintained: Hold | $112 → $130 | $124.30 | +4.59% | 53 | Jul 29, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $45 | $50.94 | -11.65% | 51 | Jul 28, 2026 | |
| REPL Replimune Group | Maintained: Buy | $16 | $5.40 | +196.30% | 32 | Jul 28, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $60 | $64.49 | -6.96% | 68 | Jul 27, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,300 | $1,176.33 | +10.51% | 118 | Jul 23, 2026 | |
| GILD Gilead Sciences | Rated: Buy | $174 | $129.64 | +34.22% | 78 | Jul 23, 2026 | |
| PFE Pfizer | Maintained: Buy | $30 | $24.63 | +21.80% | 54 | Jul 22, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $34 → $36 | $26.07 | +38.09% | 9 | Jul 21, 2026 | |
| INSM Insmed | Initiated Coverage: Buy | $192 | $101.46 | +89.24% | 1 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $310 | $226.32 | +36.97% | 1 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $18.02 | +99.78% | 1 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $27.38 | +111.83% | 1 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $14.17 | +224.63% | 1 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $381.23 | +4.92% | 68 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $142 | $128.16 | +10.80% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $144 → $170 | $178.36 | -4.69% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $730 | $706.00 | +3.40% | 77 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $474.44 | +26.46% | 69 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 → $300 | $256.93 | +16.76% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $92.70 | +38.08% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $15.01 | +59.95% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $39.00 | $36.18 | +7.79% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $5.75 | +143.48% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.48 | +27.74% | 10 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $48.51 | +198.91% | 20 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $74.42 | +34.37% | 30 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $48.90 | +43.15% | 9 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $72 → $112 | $132.65 | -15.56% | 4 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.40 | - | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.16 | - | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.60 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.88 → €131.68 | €143.25 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.53 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.57 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $5.57 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 → $15 | $15.62 | n/a | 6 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €135.00 → €129.00 | €24.02 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $1.32 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $3.76 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $169 → $220 | $27.40 | n/a | 2 | Feb 24, 2020 |
Biogen
Jul 30, 2026
Reiterated: Hold
Price Target: $196 → $208
Current: $206.68
Upside: +0.64%
Incyte
Jul 29, 2026
Maintained: Hold
Price Target: $112 → $130
Current: $124.30
Upside: +4.59%
Novo Nordisk
Jul 28, 2026
Reiterated: Hold
Price Target: $45
Current: $50.94
Upside: -11.65%
Replimune Group
Jul 28, 2026
Maintained: Buy
Price Target: $16
Current: $5.40
Upside: +196.30%
Bristol-Myers Squibb Company
Jul 27, 2026
Reiterated: Hold
Price Target: $60
Current: $64.49
Upside: -6.96%
Eli Lilly and Company
Jul 23, 2026
Maintained: Buy
Price Target: $1,300
Current: $1,176.33
Upside: +10.51%
Gilead Sciences
Jul 23, 2026
Rated: Buy
Price Target: $174
Current: $129.64
Upside: +34.22%
Pfizer
Jul 22, 2026
Maintained: Buy
Price Target: $30
Current: $24.63
Upside: +21.80%
ACADIA Pharmaceuticals
Jul 21, 2026
Reiterated: Buy
Price Target: $34 → $36
Current: $26.07
Upside: +38.09%
Insmed
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $192
Current: $101.46
Upside: +89.24%
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $310
Current: $226.32
Upside: +36.97%
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $18.02
Upside: +99.78%
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $27.38
Upside: +111.83%
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $14.17
Upside: +224.63%
Jul 13, 2026
Maintained: Buy
Price Target: $400
Current: $381.23
Upside: +4.92%
Jul 13, 2026
Maintained: Buy
Price Target: $135 → $142
Current: $128.16
Upside: +10.80%
Jul 13, 2026
Maintained: Hold
Price Target: $144 → $170
Current: $178.36
Upside: -4.69%
Jul 13, 2026
Maintained: Buy
Price Target: $730
Current: $706.00
Upside: +3.40%
Jul 13, 2026
Maintained: Buy
Price Target: $600
Current: $474.44
Upside: +26.46%
Jul 13, 2026
Maintained: Buy
Price Target: $258 → $300
Current: $256.93
Upside: +16.76%
Jul 13, 2026
Maintained: Buy
Price Target: $128
Current: $92.70
Upside: +38.08%
Jul 13, 2026
Maintained: Buy
Price Target: $24
Current: $15.01
Upside: +59.95%
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $39.00
Current: $36.18
Upside: +7.79%
Jun 30, 2026
Maintained: Buy
Price Target: $14
Current: $5.75
Upside: +143.48%
Jun 17, 2026
Maintained: Buy
Price Target: $7
Current: $5.48
Upside: +27.74%
Jun 5, 2026
Maintained: Buy
Price Target: $145
Current: $48.51
Upside: +198.91%
Jun 2, 2026
Maintained: Buy
Price Target: $100
Current: $74.42
Upside: +34.37%
Mar 18, 2026
Reiterated: Buy
Price Target: $70
Current: $48.90
Upside: +43.15%
Oct 13, 2025
Maintained: Buy
Price Target: $72 → $112
Current: $132.65
Upside: -15.56%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $33.40
Upside: -
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $8.16
Upside: -
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $3.60
Upside: n/a
Oct 23, 2024
Maintained: Buy
Price Target: €115.88 → €131.68
Current: €143.25
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $9.53
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $6.57
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $30 → $27
Current: $5.57
Upside: n/a
Dec 16, 2020
Upgraded: Buy
Price Target: $9 → $15
Current: $15.62
Upside: n/a
Oct 16, 2020
Maintained: Hold
Price Target: €135.00 → €129.00
Current: €24.02
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $1.32
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $3.76
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $169 → $220
Current: $27.40
Upside: n/a